Qianjin Pharmaceutical announced that the company and its subsidiary Qianjin Xiangjiang Pharmaceutical participated in the 12th batch of national drug procurement tenders on July 31, 2026. A total of 4 products are to be selected, including didroprogesterone tablets, alamod tablets, baritinib tablets, and agliptin benzoate tablets. The procurement period starts from the date of implementation of the selection results to December 31, 2029.

Zhitongcaijing · 2d ago
Qianjin Pharmaceutical announced that the company and its subsidiary Qianjin Xiangjiang Pharmaceutical participated in the 12th batch of national drug procurement tenders on July 31, 2026. A total of 4 products are to be selected, including didroprogesterone tablets, alamod tablets, baritinib tablets, and agliptin benzoate tablets. The procurement period starts from the date of implementation of the selection results to December 31, 2029.